Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000899923-22-000092
Filing Date
2022-06-06
Accepted
2022-06-06 16:21:21
Documents
5
Effectiveness Date
2022-06-06

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8espp.htm S-8 52598
2 EX-FILING FEES mygn-ex107toformsx8espp.htm EX-FILING FEES 18404
3 EX-5.1 ex-51mintzopiniontosx8_2022.htm EX-5.1 8757
4 EX-23.1 mygns-8xex231consent.htm EX-23.1 2341
5 picture1a.jpg GRAPHIC 8690
  Complete submission text file 0000899923-22-000092.txt   95159
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265441 | Film No.: 22998362
SIC: 2835 In Vitro & In Vivo Diagnostic Substances